Jim Cramer on Merck & Co.: “If We're Really Going Into an Oil Shock-Induced Slowdown, I Think This One's Likely an Outperformer”” [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
higher energy costs and economic uncertainty . Cramer was bullish on the stock as he stated: Next, let's check out the daily chart of Merck, which, remember, is a lot based on Keytruda, an amazing oncological drug. Lang says this is another stock with good money flow… Chaikin Money Flow. It's in very bullish territory…. Money managers are happily accumulating the shares. Merck's quietly rallied 39% since the end of October with an intact uptrend and a series of higher highs and higher lows. Not long ago, Merck pulled back below its 50-day moving average, but over the last couple of days, it's broken out again that key level. It's very bullish. Of course, Merck has still pulled back significantly from its February highs. But if you look at the chart, Lang points out that recent sell-offs of about 3 to 8% have been ideal entry points in Merck. And that's exactly what we had this month before the stock caught a bid this week. I want you to wait for the next one. I think that this one
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck Targets Post Keytruda Future With US$6.7b Terns Acquisition [Yahoo! Finance]Yahoo! Finance
- Agilent receives FDA approval for PD-L1 1HC 22C3 pharmDx [Yahoo! Finance]Yahoo! Finance
- Merck's deal for Terns sparks debate over a possible biotech bidding war [Yahoo! Finance]Yahoo! Finance
- RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over “Modest Premium” [Yahoo! Finance]Yahoo! Finance
- Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline [MSNBC.com]MSNBC.com
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/12/26 - Form 3
- 2/24/26 - Form 10-K
- MRK's page on the SEC website